Skip to content

Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01886729
Enrollment
Unknown
Registered
2013-06-26
Start date
2012-04-30
Completion date
Unknown
Last updated
2013-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

transcranial direct current stimulation, time shift

Brief summary

The treatment for patients with acute tinnitus consists of Methylprednisolone and hyperbaric oxygen therapy. For this study transcranial direct current stimulation (tDCS) was added to the protocol. The purpose is to determine the effect of the time shift of tDCS. Two conditions will be compared: tDCS simultaneously with the hyperbaric oxygen therapy or tDCS 3 weeks after the start of the tinnitus. An audiological testing will be performed at the day of admission, after 3 weeks, 6 weeks and 12 weeks.

Interventions

OTHERtranscranial direct current stimulation (tDCS)

Sponsors

University Hospital, Antwerp
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years

Inclusion criteria

* age between 18 and 50 years * presence of acute tinnitus or worsening of tinnitus caused by otogenic disease * registration in UZA within 48 hours after start tinnitus * VAS-score ≥ 4 * ability to understand and sign informed consent

Exclusion criteria

* history of epileptic seizures * severe organic comorbidity * psychiatric disorders or a history of psychiatric disorders with psychotic symptoms * Pace maker * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Improvement of tinnitus12 weeksTinnitus Questionnaire, Visual Analog Scale, Beck Depression Index, Hyperacusis questionnaire

Secondary

MeasureTime frameDescription
Hearing12 weeksAudiometry, Otoacoustic emissions, Tympanometry, Speech in noise

Countries

Belgium

Contacts

Primary ContactSarah Rabau
sarah.rabau@uza.be003238215235

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026